Invesco Ltd. Rigel Pharmaceuticals Inc Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.12 - $1.57 $1,149 - $1,610
1,026 Added 1.21%
85,496 $126,000
Q4 2023

Feb 12, 2024
SELL
$0.72 - $1.56 $6,193 - $13,419
-8,602 Reduced 9.24%
84,470 $122,000
Q3 2023

Nov 13, 2023
BUY
$1.07 - $1.39 $5,645 - $7,333
5,276 Added 6.01%
93,072 $100,000
Q2 2023

Aug 11, 2023
BUY
$1.12 - $1.82 $4,763 - $7,740
4,253 Added 5.09%
87,796 $113,000
Q1 2023

May 12, 2023
SELL
$1.25 - $2.0 $107,443 - $171,910
-85,955 Reduced 50.71%
83,543 $110,000
Q4 2022

Feb 13, 2023
SELL
$0.67 - $11.9 $3.35 Million - $59.5 Million
-4,998,915 Reduced 96.72%
169,498 $254,000
Q3 2022

Nov 14, 2022
BUY
$1.1 - $12.2 $9,401 - $104,273
8,547 Added 0.17%
5,168,413 $6.1 Million
Q2 2022

Aug 15, 2022
SELL
$0.67 - $3.19 $1,240 - $5,904
-1,851 Reduced 0.04%
5,159,866 $5.83 Million
Q1 2022

May 16, 2022
SELL
$2.22 - $3.45 $1,070 - $1,662
-482 Reduced 0.01%
5,161,717 $15.4 Million
Q4 2021

Feb 14, 2022
SELL
$2.36 - $3.57 $44,245 - $66,930
-18,748 Reduced 0.36%
5,162,199 $13.7 Million
Q3 2021

Nov 15, 2021
BUY
$3.5 - $4.5 $56,654 - $72,841
16,187 Added 0.31%
5,180,947 $18.8 Million
Q2 2021

Aug 17, 2021
BUY
$3.09 - $4.54 $73,625 - $108,174
23,827 Added 0.46%
5,164,760 $22.4 Million
Q1 2021

May 17, 2021
BUY
$3.35 - $4.93 $48,039 - $70,696
14,340 Added 0.28%
5,140,933 $17.6 Million
Q4 2020

Feb 16, 2021
BUY
$2.35 - $3.74 $268,741 - $427,698
114,358 Added 2.28%
5,126,593 $17.9 Million
Q3 2020

Nov 16, 2020
BUY
$1.78 - $4.13 $843 - $1,957
474 Added 0.01%
5,012,235 $12 Million
Q2 2020

Aug 14, 2020
BUY
$1.41 - $2.05 $91 - $133
65 Added 0.0%
5,011,761 $9.17 Million
Q1 2020

May 15, 2020
BUY
$1.27 - $3.0 $14,687 - $34,695
11,565 Added 0.23%
5,011,696 $7.82 Million
Q2 2019

Aug 14, 2019
BUY
$2.02 - $2.61 $10.1 Million - $13.1 Million
5,000,131 New
5,000,131 $13.1 Million

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email